Wordt geladen...
Advantage of using a recombinant activated factor VII in traumatic haemorrhagic shock: The Bordeaux experience
INTRODUCTION: Several series of patient studies have been published on the use of rFVIIa in traumatic haemorrhagic shock, although to date no international recommendations have been produced. France does not currently recognise traumatic haemorrhagic shock as an appropriate indication for the use of...
Bewaard in:
| Hoofdauteurs: | , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Medknow Publications & Media Pvt Ltd
2012
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3391838/ https://ncbi.nlm.nih.gov/pubmed/22787344 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0974-2700.96483 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|